UB Paderborn / Katalog / Suche / in CDI

A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines

Journal of inorganic biochemistry, 2010-05, Vol.104 (5), p.503-511

2010

Volltextzugriff (PDF)

Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells

The Journal of steroid biochemistry and molecular biology, 2002-09, Vol.82 (1), p.45-53

2002

Volltextzugriff (PDF)

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

JAMA oncology, 2016-02, Vol.2 (2), p.217

2016

Volltextzugriff (PDF)

Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells

Journal of molecular endocrinology, 2007-08, Vol.39 (2), p.105-118

2007

Volltextzugriff (PDF)

Effect of Fluorination on the Pharmacological Profile of 11β Isomers of Fulvestrant in Breast Carcinoma Cells

Journal of medicinal chemistry, 2009-02, Vol.52 (3), p.883-887

2009

Volltextzugriff (PDF)

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif—Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Biochemical pharmacology, 2010-03, Vol.79 (5), p.746-757

2010

Volltextzugriff (PDF)

Estrogens decrease γ-ray–induced senescence and maintain cell cycle progression in breast cancer cells independently of p53

International journal of radiation oncology, biology, physics, 2007-03, Vol.67 (4), p.1187-1200

2007

Volltextzugriff (PDF)

Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells

Biochemical pharmacology, 2007-10, Vol.74 (7), p.1029-1038

2007

Volltextzugriff (PDF)

Fluorous tolerance of the estrogen receptor alpha as probed by 11-polyfluoroalkylestradiol derivatives

Steroids, 2008-03, Vol.73 (3), p.320-327

2008

Volltextzugriff (PDF)

Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells

Current cancer drug targets, 2006-02, Vol.6 (1), p.39

2006

Volltextzugriff (PDF)

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha

Breast cancer research and treatment, 2006-09, Vol.99 (2), p.121-134

2006

Volltextzugriff (PDF)

Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment

Current pharmaceutical design, 2011, Vol.17 (25), p.2632

2011

Volltextzugriff (PDF)

SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

NPJ breast cancer, 2019-05, Vol.5 (1), p.16, Article 16

2019

Volltextzugriff (PDF)

Tumor Banks: A Quality Control Scheme Proposal

Frontiers in medicine, 2019-10, Vol.6, p.225-225

2019

Volltextzugriff (PDF)

Loss of antagonistic activity of tamoxifen by replacement of one N-methyl of its side chain by fluorinated residues

Bioorganic & medicinal chemistry, 2006-11, Vol.14 (22), p.7531-7538

2006

Volltextzugriff (PDF)

ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays

Journal of receptors and signal transduction, 2017-03, Vol.37 (2), p.149-166

2017

Volltextzugriff (PDF)

Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens

The Journal of steroid biochemistry and molecular biology, 2003-11, Vol.87 (2), p.207-221

2003

Volltextzugriff (PDF)

Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells

Bioorganic & medicinal chemistry, 2007-03, Vol.15 (6), p.2269-2282

2007

Volltextzugriff (PDF)

Trophic effect in MCF-7 cells of ERα17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor α—Underlying mechanisms

The Journal of steroid biochemistry and molecular biology, 2008, Vol.109 (1), p.138-149

2008

Volltextzugriff (PDF)

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Biochemical pharmacology, 2010-03, Vol.79 (5), p.746-57

2010

Volltextzugriff (PDF)

Calmodulin-independent, agonistic properties of a peptide containing the calmodulin binding site of estrogen receptor α

Molecular and cellular endocrinology, 2007-03, Vol.268 (1), p.37-49

2007

Volltextzugriff (PDF)

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif – Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Biochemical pharmacology, 2009-12, Vol.79 (5)

2009

Volltextzugriff (PDF)

Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells

The Journal of steroid biochemistry and molecular biology, 2005-03, Vol.94 (4), p.347-359

2005

Volltextzugriff (PDF)

Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells

Steroids, 2000-12, Vol.65 (12), p.903-913

2000

Volltextzugriff (PDF)

Pharmacological Profile of 6,12-Dihydro-3-methoxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one, a Novel Human Estrogen Receptor Agonist

Biological and Pharmaceutical Bulletin, 2002, Vol.25(3), pp.335-341

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines

Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

Effect of nuclear export inhibition on estrogen receptor regulation in breast cancer cells

Effect of Fluorination on the Pharmacological Profile of 11β Isomers of Fulvestrant in Breast Carcinoma Cells

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif—Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Estrogens decrease γ-ray–induced senescence and maintain cell cycle progression in breast cancer cells independently of p53

Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells

Fluorous tolerance of the estrogen receptor alpha as probed by 11-polyfluoroalkylestradiol derivatives

Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells

Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha

Peptides targeting estrogen receptor alpha-potential applications for breast cancer treatment

SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

Tumor Banks: A Quality Control Scheme Proposal

Loss of antagonistic activity of tamoxifen by replacement of one N-methyl of its side chain by fluorinated residues

ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays

Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens

Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells

Trophic effect in MCF-7 cells of ERα17p, a peptide corresponding to a platform regulatory motif of the estrogen receptor α—Underlying mechanisms

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Calmodulin-independent, agonistic properties of a peptide containing the calmodulin binding site of estrogen receptor α

Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif – Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells

Role of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cells

Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells

Pharmacological Profile of 6,12-Dihydro-3-methoxy-1-benzopyrano[3,4-b][1,4]benzothiazin-6-one, a Novel Human Estrogen Receptor Agonist

Suchergebnisse filtern